Cross Labcell News Today

Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The

/PRNewswire/ -- The "Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts" report has been added to...

Brining Expertise in NK Cell Therapy to Advance Efforts in Cancer Prevention, early detection, and treatment development ▶ New focus on NK cell therapy for...

/PRNewswire/ -- The "Global Drug Delivery Partnering Terms and Agreements 2016-2023" report has been added to ResearchAndMarkets.coms offering. The Global...

Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Drug Delivery Partnering Terms and Agreements 2016-2023" report has been added to ...

/PRNewswire/ -- The "Global Drug Delivery Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.coms offering. The Global...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation. GC Pharma Reports Q1 2021 Results April 29, 2021 GMT YONGIN, South Korea--(BUSINESS WIRE)--Apr 28, 2021-- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months ended 31 March 2021. First-Quarter Reported Results(1)   (2) Financial Highlights Delivered total revenue dec...

Press release content from Business Wire. The AP news staff was not involved in its creation. GC Pharma Reports Full Year 2020 Results February 9, 2021 GMT YONGIN, South Korea--(BUSINESS WIRE)--Feb 9, 2021-- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited financial results for the year ended 31 December 2019. Key Figures (1) - (1) Results from continuing operations (Green Cross MS’ blood bag business has ...